Drexel University, College of Medicine, Clinical Research Group

Philadelphia, Pennsylvania 19102

0 studies enrolling now · 3 studies all time

What they study most

B-cell Chronic Lymphocytic Leukemia, Hyperbilirubinemia, Neonatal, Relapsed or Refractory Chronic Lymphocytic Leukemia

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
• A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia — Stopped early
• Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia — Completed